Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,789 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $473.57 | 8 | $0 (2024) |
| SOBI, INC | $332.87 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $328.55 | 7 | $0 (2024) |
| ABBVIE INC. | $246.08 | 2 | $0 (2024) |
| Eisai Inc. | $240.68 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $153.01 | 2 | $0 (2023) |
| SERVIER PHARMACEUTICALS LLC | $125.00 | 1 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $114.30 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $99.92 | 1 | $0 (2023) |
| Agios Pharmaceuticals, Inc. | $93.53 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,829 | 39 | AstraZeneca Pharmaceuticals LP ($246.67) |
| 2023 | $960.13 | 10 | AstraZeneca Pharmaceuticals LP ($226.90) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.09 | General |
| Category: Hematology/Oncology | ||||||
| 12/05/2024 | Azurity Pharmaceuticals, Inc. | VIVIMUSTA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $86.31 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $17.93 | General |
| 11/16/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $34.80 | General |
| Category: Hematology | ||||||
| 11/11/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $45.98 | General |
| Category: Oncology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug), TECVAYLI | Food and Beverage | In-kind items and services | $118.40 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $93.53 | General |
| Category: Genetically Defined Disease | ||||||
| 10/23/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $38.53 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 24 | 34 | $6,290 | $1,792 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 34 | $6,290 | $1,792 | 28.5% |
About Chan Ly
Chan Ly is a Case Management healthcare provider based in Olympia, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2020. The National Provider Identifier (NPI) number assigned to this provider is 1932736121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chan Ly has received a total of $2,789 in payments from pharmaceutical and medical device companies, with $1,829 received in 2024. These payments were reported across 49 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,789).
As a Medicare-enrolled provider, Ly has provided services to 24 Medicare beneficiaries, totaling 34 services with total Medicare billing of $1,792. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Case Management
- Other Specialties Nurse Practitioner
- Location Olympia, WA
- Active Since 03/26/2020
- Last Updated 09/11/2024
- Taxonomy Code 163WC0400X
- Entity Type Individual
- NPI Number 1932736121
Products in Payments
- ENHERTU (Biological) $282.30
- EPKINLY (Drug) $246.08
- Lenvima (Drug) $240.68
- ERLEADA (Drug) $238.56
- VONJO (Drug) $210.75
- RYBREVANT (Drug) $177.77
- XARELTO (Drug) $153.01
- Doptelet (Drug) $122.12
- LYNPARZA (Drug) $101.90
- Trodelvy (Drug) $99.92
- PYRUKYND (Drug) $93.53
- KEYTRUDA (Biological) $92.20
- CALQUENCE (Drug) $74.50
- KISQALI (Drug) $58.04
- Orserdu (Drug) $55.02
- Pomalyst (Drug) $34.80
- BRUKINSA (Drug) $31.59
- FRUZAQLA (Drug) $28.88
- DARZALEX (Biological) $26.52
- VERZENIO (Drug) $25.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.